Medtech’s focus on the service of patients, practitioners and hospitals
Medtech’s mission statement can be summarized in the following way: Our mission consists of the broader use of medical technology for the benefit of both patient and practitioner as we strive for improved overall health and well-being.
Medtech designs, develops and markets a new generation of robotic assistance for the express purpose of improved surgical techniques. Our robots contribute to safer and more stable implementation of both more effective and less invasive treatment.
A Question of Innovation
Medtech is a market leader in surgical robotics in France thanks, in large part, to its ongoing commitment to continuous innovation since its inception in 2002.
Awards and Distinctions
Medtech has been honored again for its excellent performance in the 2015 Technology Fast 50 Awards for the Mediterranean Area. Medtech distinguished itself in the "listed Company" category by displaying a strong progression in its activities with an increase of +158% between 2014 and June 30, 2015. As of September 30, 2015, the Company has sold 51 ROSA™ robots worldwide and more than 2,600 procedures have been performed.
Medtech receives the Frost & Sullivan "Excellence in Best Practices" Award. Frost & Sullivan emphazise Medtech's development strategy. In just 10 years, the company has become a key international player in the field of surgical robotics for the central nervous system.
Medtech is the 2014 "Revelation" prizewinner in the Mediterranean Deloitte Technology Fast 50 Awards. Medtech is proud to have won the 2014 "Revelation" prize. The regional Techonology Fast 50 2014 jury chose to reward Medtech not only for its excellent performance in increasing its sales figures, but also for its strong capacity for technological innovation.
Medtech, 2013 European Surgical Robotics Company of the Year: Medtech is pleased to announce that it has received the Frost & Sullivan European Surgical Robotics Company of the Year Award for neurosurgical inventions.
Frost & Sullivan, the “Growth Partnership Company” commended Medtech for its innovative ROSA™ system, the latest generation in robotics to work alongside neurosurgeons to provide guaranteed accuracy relative to a frame-based stereotactic system and is ergonomically superior to a standard navigation system.
